CareHarmony

A nurse calls a stranger in Texas. That is the product.

Somewhere in East Texas, a woman with two chronic conditions picks up her phone. The voice on the other end knows her medication list, noticed she missed a refill, and asks how the new dosage is sitting. The woman has never met this person. She never will. And yet, statistically, that call is part of why she will not end up in an emergency room this month.

That call is CareHarmony. Not an app she downloads, not a portal she logs into - a care team in Brentwood, Tennessee, acting as an extension of her own doctor's office, reaching out in the long, quiet stretch between visits. More than 100,000 patients now sit on the other end of calls like that one. Forty-plus hospitals and health systems, across twenty-plus states, have handed CareHarmony the part of medicine that everyone agrees matters and almost no one is staffed to do.

Medicine ends the appointment. The illness does not.

Here is the inconvenient arithmetic of chronic disease. A patient with diabetes might see their physician four times a year - call it two hours of clinical attention out of roughly 8,760 hours of being alive and sick. The other 8,758 hours are where the disease actually happens: the skipped dose, the swelling ankle, the ride to dialysis that fell through, the question nobody was around to answer.

Everyone in healthcare knows this. Medicare even pays for the fix - chronic care management, transitional care, remote monitoring, wellness visits are all reimbursable. The catch, and it is a real one, is that running those programs well requires nurses making thousands of phone calls, reading thousands of charts, and somehow knowing which patient needs a call today. Most hospitals look at that operational mountain and quietly decide not to climb it.

So the money sits on the table. The patients sit at home. And the readmission, when it comes, surprises absolutely no one.

Hire the nurses. Build the brain. Charge nothing up front.

Gokul Mohan co-founded CareHarmony in 2015 on a wager that sounds obvious and almost never works: that you could take the unglamorous, labor-heavy work of between-visit care, do it on behalf of hospitals, and make the economics pencil out for everyone. The trick was refusing to treat it as purely a software problem or purely a staffing problem.

The bet had three legs. First, real people - clinical care teams who actually call patients, because chronic disease is managed in conversations, not dashboards. Second, machine learning to decide who those people call and why, because 100,000 patients is far too many to triage by gut. Third, and most disarming, a $0-upfront model: partners pay as the preventative-care revenue and savings materialize, which neatly removes the excuse every CFO reaches for first.

CareBlocks reads the data. Symphony plays it.

The technology has an earnest name - CareBlocks, delivered through a platform called Symphony - and a genuinely useful job. It takes a patient's clinical record and their insurance claims, then enriches both with social data: housing, transportation, isolation, the messy off-chart facts that decide whether a care plan survives contact with real life. From that, it stratifies risk and recommends which intervention to run next, for which patient, now.

CareHarmony calls the result "adaptive care delivery" - teams watch whether an intervention is working and adjust in real time. The practical upshot is leverage: a care team augmented this way can responsibly cover a patient population on the order of ten times larger than it could armed with a spreadsheet and good intentions. The programs themselves are the familiar, reimbursable four. The difference is they actually get run.

Ten years, told in receipts.

The skeptic's section. Bring the numbers.

Mission statements are cheap. So here is the part that is harder to fake: CareHarmony's Medicare Shared Savings Program partners reached shared savings 95% of the time - and in the most recently reported performance year, every single one of them did. Their ACO partners booked combined cost savings north of $100 million in a single year. That is the rare healthcare claim where the payer, the provider, and the patient all come out ahead at once.

Value-based care keeps getting talked about. Someone has to staff it.

For two decades, American healthcare has promised to pay for outcomes instead of activity - value-based care, the phrase that launched a thousand panels. The promise keeps stalling on the same rock: outcomes require attention between visits, and attention between visits requires people and judgment at a scale nobody had built. CareHarmony's mission is almost boring in its directness - "make it possible to deliver personalized, coordinated care to every patient" - and that is precisely the point. It is an operational mission, not a poetic one.

The company is backed to chase it. Maverick Ventures and Nashville Capital Network put money behind a model that only wins if patients actually do better, since the revenue rides on shared savings and reimbursable outcomes. It is a healthcare bet with the incentives pointed, for once, in a sensible direction.

Back to the phone call.

The population of Americans living with multiple chronic conditions is going up, not down, and the supply of nurses to manage them is not keeping pace. That gap is the whole game. The future CareHarmony is building toward is not flashier medicine - it is medicine that simply does not drop the patient the moment the visit ends. Machine learning to find the person who needs the call; real people to make it.

So return to East Texas. The woman with two chronic conditions hangs up the phone. Her refill is sorted, her question is answered, and the emergency room she didn't visit will never know it lost a customer. She still has never met the person who called - and under the system CareHarmony is quietly assembling, she shouldn't have to. The care found her anyway. That is the change: not a closed chart, but an open line.